-
Product Insights
Colonial Eagle – Whitakers Solar PV Park
Colonial Eagle - Whitakers Solar PV Park is a solar PV project located in North Carolina, United States. The project is owned by Duke Energy Renewables Inc and was developed by SunEnergy1. The project came online in 2015. Empower your strategies with our Colonial Eagle - Whitakers Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
Colonial Trail West Solar PV Park
Colonial Trail West Solar PV Park is a solar PV project located in Virginia, United States. The project is owned by Virginia Electric and Power Co and was developed by Dominion Energy Inc; Urban Grid Solar Inc. The project came online in 2019. Empower your strategies with our Colonial Trail West Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axatilimab in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axatilimab in Graft Versus Host Disease (GVHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axatilimab in Graft Versus Host Disease (GVHD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axatilimab in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axatilimab in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axatilimab in Idiopathic Pulmonary Fibrosis Drug Details: Axatilimab (SNDX-6352) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Anumigilimab in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anumigilimab in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anumigilimab in Rheumatoid Arthritis Drug Details: Anumigilimab (CSL324) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Axatilimab in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axatilimab in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axatilimab in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Axatilimab (SNDX-6352)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AMB-051 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMB-051 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMB-051 in Non-Small Cell Lung Cancer Drug Details: AMB-051 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gene Therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naxitamab in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naxitamab in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naxitamab in Triple-Negative Breast Cancer (TNBC) Drug Details: Naxitamab (Danyelza)...